INTRODUCTION
The activation of the complement (C) system by the alternate pathway whereby the earlier components C1, C4, and C2 are not involved is gaining increasing importance. This pathway involves a serum factor recently delineated by Gbtze and Miller-Eberhard as the C3PA (1). Goodkofsky and Lepow (2) This report concerns the activation of C3, C5, and C7 in the serum of a 9-yr old girl after incubation at 0C for 6-8 h without utilization of C1, C4, and C2. The patient has upper respiratory infections associated with recurrent gross hematuria, focal glomerulonephritis, and transient renal insufficiency. The child was first noted to have gross hematuria at the age of 5 yr. At this time the hematuria was attributed to a urinary tract infection. A second episode of hematuria occurred when the patient was 8 yr of age and at this time a diagnosis of focal glomerulonephritis was made. In more recent months, the episodes of hematuria and infections have increased in frequency and at least a dozen attacks have occurred over the past year.
Three kidney biopsies were performed in 1971 (April, June, and November), BMc and fibrinogen were detectable to a varying degree along the glomerular basement membrane in a granular distribution. In a most recent study of the renal tissue (December 1972) properdin and IgA which were previously absent, could also be demonstrated. IgG, IgM, and C3PA were lacking in all tissues. It is the purpose of this report to detail our studies of the complement system and its activation in this patient. Evidence will be presented to indicate that the complement system of this patient is activated through C3 at 0C. This activation requires the patient's IgA.
MET-HODS
Buffers for C assays. The disodium salt of ethylenediaminetetracetic acid reagent grade NaH2 EDTA was titrated to a pH 4 at a stock concentration of 0.15 M. Na2 Mg2EDTA (Geigy Chemical Corp., Ardsley, N. Y.) was also titrated to pH 4 at a stock concentration of 0.15 M. Gelatin veronal buffer and glucose gelatin veronal buffer with and without Ca`* and Mg-+ (GGV++, GGV--) were prepared as described previously (3) .
Serum. Blood was allowed to clot for 1 h at room temperature. The serum was removed after centrifugation at 4VC, aliquoted, and stored at -70'C until used. Guinea pig C2. Partially purified C2 was prepared from guinea pig serum (Texas Biological Laboratory, Inc., Ft. Worth, Tex.) according to the method described by Nelson, Jensen, Gigli, and Tamura (4).
EAC1, EAC1,4, and EAC4. Cell intermediates with C1 were prepared according to methods described previously (5, 6) .
Assays of total complement (CH50) and the C components. Sensitation of erythrocytes from sheep (3) and the measurement of total complement in 50% hemolytic units (CH50) was carried out as described previously (7) .
Assays of human Cl, C4, and C2 were determined according to published methods (5) .
Assays of human C3, C5, C6, C7, C8, and C9. Functionally pure C components for the assays of these components and EAClgp4-7hu for use in assay of C8 and C9
were obtained from Cordis Laboratories (UMiami, Fla.) and the assays were carried out according to the method described by Nelson et al. (4) . The experimental error of the C components 1-9 ranged between 5 and 10%. Clq, Cls, and C3PA were carried out by the Mancini technique' (8) .
Conversion of C3 was determined by immunoelectrophoresis using antisera against purified C3.
Conversion of C3PA was determined by immunoelectrophoresis according to the method of Gdtze and MufllerEberhard (1) after treatment with inulin and with antisera against purified C3PA.' Bactericidal activity was measured according to the method of Muschel and Treffers (9) using an Eschericluia coli rough strain.
Phagocytic activity was measured according to the standard methods used in this laboratory adapted to using Pseiidomonas aeruginosa type I (10) 2 Alethod of isolation of active factor. 3 ml of the patient's plasma was applied to a 45 X 30 cm block of Pevikon C-870 (11) (Mercer Consolidated Corp., New York) prepared with barbital buffer, pH 8.6, ionic strength 0.05. The sample was applied at the cathodal region, electrophoresis was carried out at 350 V for approximately 18 h at 4VC. The blocks were cut into 11-cm segments and were eluted with barbital buffer. The eluates were analyzed for protein by Folin's method.
Assay of active fraction. Approximately 0.7 mg/ml of each fraction was reacted with 100 Mul of normal serum for 2 h at 370C. The mixture was serially diluted in GGV++.
0.1 ml of EA1 X 108/ml was then added to each tube and total hemolytic C was determined. The active factor appeared at the cathodal area and this fraction was concentrated in an Amicon ultrafiltration device (Amicon Corp., Lexington, Mass.) using the membrane filter UM-10. Purification by, imninunoadsorptioni. Monospecific antiserum to IgA prepared according to methods described by Litman and Good (12) was coupled to activated, washed Sepharose according to previously described method (13) .
The antisera wdere shown to be specific for IgA by the methods outlined in the presentation of Litman and Good (12) . 2 (Table II) . Similarly, C8 and C9 were not reduced after incubation in the cold. The drop of hemolytic C3 was associated with conversion of C3 (Fig. 3) by inimunoelectrophoretic analysis, and the formation of a diffuse ring when C3 was assayed by the MA~ancini technique (8) .
This conversion was unaffected when fresh serum was previously centrifuged at 20,000 rpm for 1 h suggesting that the activation was independent of any membranes or particulate matter that could have been present in the serum. C3 proactivator as assayed by the MIancini technique in the fresh sample was reduced to 50% of the normal value (Table II) . No further decrease in concentration was observed after incubation at 0°C. Although conversion of C3PA by inulin could be demonstrated in fresh or in serum kept at -700C, conversion of C3PA by intulin was not demonstrable after the serum had been incubated in the cold (Figs. 4 and 5 ). This finding suggests that either maximal conversion of C3PA had occurred after incubation or that cofactors responsible for conversion of C3PA had been depleted by the incubation. When the patients serum was de- pleted of C3PA by adsorption through a Sepharose column containing specific anti-C3PA and incubated overnight at 0C, the activation of C was reduced by 50% (Table III) 
this concentration of MAg`+ indicating that the activation at 0°C required Mg++ ions. No change in total hemolytic C was observed when Ca`+ ions were substituted for Mg`+ in the above experiment.
Bactericidal and phagocvtic activity. Studies of the bactericidal activity of the patient's serum before and after incubation at 00C are presented in Table IV . As indicated, a 40-fold increase in the volume of the patient's serum was required to exhibit bactericidal activitv after incubation at 0C as compared with fresh unincubated serum. Similarly, evidence that a phagocytic defect for P. aeruginosa appeared upon incubation at 00C is presented in Fig. 7 .
Isolation of active factor by Pevikon block clectrophoresis. WNhen the normal serum was incubated with 17 plasma fractions from Pevikon block at 0°C overnight and then assayed for total hemolytic complement by the microtiter method, it was found that the third fraction was most anticonmplementary. The experiment was set up again as above, using three fractions, fractions 2, 3, and 17 and the total hemolytic complement CH50 was determined by macrotiter. Purification by! imimunoadsorption. When the patient's plasma which had been adsorbed by a Sepharose column containing antiserum specific for IgA was incubated wvith MIgf+ (2 mg/ml) overnight at 0°C, the CH50 activity dropped only by 4% as compared with unadsorbed control patient's plasma which was incubated with Mg++ at 0C overnight. The C activity in the control plasma dropped by greater than 95%. (Table VI) .
Similarly, when the above specific IgA adsorption was repeated with the patient's serum and the adsorbed serum then incubated overnight at 0°C, the drop in hemolytic C was only 20% and no conversion of C3 could be demonstrated (Fig. 8) (Table VII) . These experiments indicated that IgA is responsible for activation of the C system in this patient's serum. In order to determine whether the Sepharose alone was absorbing nonspecifically one or more proteins involved in the activation of C3 in the cold, patient's plasma was applied to a Sepharose column not charged with any antiserum. The fractions containing the highest activity of hemolytic C were left overnight at 0°C with Mg". As shown in Table   E Approximately 0.7 mg/ml of each fraction was reacted with 100 Ml of normal serum for 2 h at 370C. The mixture was diluted in GGX ++. 0.1 ml of EA1 X 108n ml was then added to each tube and total hemolvtic C was determined.
The results represent percent inhibition of total CH50 when compared with the control fraction-fraction 17.
antisera against IgG, IgM\, IgA, and JgD, none of the immunoglobulins were removed nor was C3PA removed. A control experiment to determine whether IgG was involved in the activation of C3 was then executed. Since it was difficult to remove IgG completely from the patients serum by a single immunoadsorption and since subsequent adsorptions led to a high dilution of the serum, the following experiment was carried out.
The patient's plasma was applied to a Pevikon block and those fractions containing a mixture of IgG and IgA were added to normal serum and incubated at 00C overnight. Inhibition of CH50 activity in the normal serum occurred. The IgA from these fractions was removed on Sepharose column containing anti-IgA. The purity of these adsorbed fractions was established by immunoelectrophoresis and Ouchterlony (Fig. 9) .
These fractions were then added to normal human Yes the C systenm in the cold from either the patient's or normal sera.
Although present understanding of the complement system, the so-called alternate pathway, and the relationships of these to the properdin system are not yet sufficiently definitive to permit us to explain completely the association of recurrent renal disease with the unusual cold activation of the complement system that we have observed in the serum of our patient, it seems certain that these phenomena are intimately related in an important way. To our knowledge, this patient's serum is unique in that its IgA activates complement in the cold without utilizing Cl, C4, and C2. The association of this unique serological process w-ith the clinical picture of recurrent hematuria in unexplained renal disease makes it necessary to look at other patients Awho have recurrent unexplained hematuria for similar serological perturbations and to look more regularlv especially in patients with renal disease and recurrent infection for evidence of spontaneous activations of the alternate pathway by the methodology that was used in the study of this patient. Since the discovery of cold activation of the complement system was accidental in this instance, it seems likely that directed search for this activation mechanism will reveal other cases that can shed light on a most provocative association.
